| dbo:abstract
|
- Annie F. Luetkemeyer is an American physician and researcher who is Professor of Medicine and Infectious Diseases at the University of California, San Francisco. She specializes in infectious diseases, in particular tuberculosis, human immunodeficiency virus and viral hepatitis. During the COVID-19 pandemic Luetkemeyer led a clinical trial of remdesivir. She has also researched treatment of COVID-19 as a co-infection with HIV. (en)
|
| dbo:activeYearsStartYear
| |
| dbo:birthName
|
- Annie F. Luetkemeyer (en)
|
| dbo:birthPlace
| |
| dbo:education
| |
| dbo:nationality
| |
| dbo:occupation
| |
| dbo:relative
| |
| dbo:stateOfOrigin
| |
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 16407 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:birthName
|
- Annie F. Luetkemeyer (en)
|
| dbp:birthPlace
|
- Baltimore, Maryland U.S. (en)
|
| dbp:caption
| |
| dbp:education
| |
| dbp:name
| |
| dbp:nationality
| |
| dbp:occupation
|
- Infectious diseases researcher (en)
|
| dbp:relatives
| |
| dbp:wikiPageUsesTemplate
| |
| dbp:yearsActive
| |
| dcterms:subject
| |
| rdf:type
| |
| rdfs:comment
|
- Annie F. Luetkemeyer is an American physician and researcher who is Professor of Medicine and Infectious Diseases at the University of California, San Francisco. She specializes in infectious diseases, in particular tuberculosis, human immunodeficiency virus and viral hepatitis. During the COVID-19 pandemic Luetkemeyer led a clinical trial of remdesivir. She has also researched treatment of COVID-19 as a co-infection with HIV. (en)
|
| rdfs:label
| |
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| foaf:name
| |
| is dbo:relative
of | |
| is dbo:wikiPageWikiLink
of | |
| is dbp:name
of | |
| is dbp:relatives
of | |
| is foaf:primaryTopic
of | |
